Clinical Trial

To Evaluate the Safety, Tolerability, Pharmacokinetics and the Effect of Food on the Hemay5259 Sustained-release Tablets in Healthy Subjects.

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Evaluation of the pharmacokinetics of Hemay 5259 sustained-release tablets in healthy human subjects
Trial Details
NCT Number NCT07703904
Lead Sponsor Hemay Pharmaceutical PTY. LTD.
Conditions Pharmacokinetics
Enrollment 32 participants
Start Date 2026-07-01
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-15